HKEX: 2157 - Lepu Biopharma Co., Ltd.

Yield per half year: +12.58%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Lepu Biopharma Co., Ltd.

en.porti.ru7.007.006.006.005.005.004.004.003.003.002.002.00Dec '23Dec '2320242024Feb '24Feb '24Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25
Download SVG
Download PNG
Download CSV

About Lepu Biopharma Co., Ltd.

Lepu Biopharma Co., Ltd., биофармацевтическая компания, занимается разработкой онкологических терапевтических средств с использованием ряда онкологических продуктов в Китае. Компания разрабатывает кандидаты в онкологические препараты, в том числе конъюгаты антитело-лекарство (ADC), онколитические вирусные препараты и иммунотерапевтические препараты.

more details
Он разрабатывает иммуноонкологические продукты, такие как mAb HX008 Anti-PD-1 и mAb LP002 Anti-PD-L1; продукты ADC, в том числе ADC, ориентированный на MRG003 EGFR, ADC, нацеленный на MRG002 HER2, ADC, нацеленный на MRG001 CD20, ADC, ориентированный на MRG004A TF, и ADC, нацеленный на CMG901 CLDNI8.2; онколитический вирус CG0070; и другие кандидаты в лекарственные средства, такие как HX008+OH2, LP002+OH2 и HX008+LP002. Компания была зарегистрирована в 2018 году и имеет штаб-квартиру в Шанхае, Китай.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN CNE100004SM4
Industry Biotechnology
Sector Health Care
Валюта hkd
Валюта отчета cny
Сайт https://www.lepubiopharma.com
Цена ао 3.49
Change price per day: -0.2857% (3.5)
Change price per week: +7.38% (3.25)
Change price per month: +7.06% (3.26)
Change price per 3 month: +11.15% (3.14)
Change price per half year: +12.58% (3.1)
Change price per year: +10.09% (3.17)
Change price per 3 year: -50.98% (7.12)
Change price per 5 year: 0% (3.49)
Change price per 10 year: 0% (3.49)
Change price per year to date: +32.7% (2.63)
All parameters

Underestimation

Title Value Grade
P/S 25.92 1
P/BV 5.98 2
P/E 0 0
EV/EBITDA -15.37 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % -0.8055 0
ROE, % -2.2 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -1.16 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 1096.59 10
Yield Ebitda, % 63.23 8
Yield EPS, % -95.35 0
Total: 3.6
More

ETFShare, %Profitability for 1 year, %Dividends, %
WisdomTree Japan Hedged SmallCap Equity Fund 0.04392 15.3 3.59912
Dimensional International Small Cap ETF 0.03925 5.69 3.34747
WisdomTree Japan SmallCap Dividend Fund 0.03604 7.75 3.58532
SPDR S&P International Small Cap ETF 0.02558 8.94 3.10348
Schwab International Small-Cap Equity ETF 0.01426 10.07 3.20638
SPDR S&P Emerging Markets Small Cap ETF 0.01385 5.46 3.03583
SPDR S&P China ETF 0.01167 17.02 3.40103
Vanguard FTSE All-World ex-US Small-Cap ETF 0.01 9.39 3.09932
Dimensional International Core Equity 2 ETF 0.00512 6.52 3.69996
Direxion Daily Japan Bull 3x Shares 0.00429 6.34 2.48436
Avantis International Equity ETF 0.00408 6.46 3.80856
Dimensional World ex U.S. Core Equity 2 ETF 0.00383 13.06 3.62488
Dimensional International Core Equity Market ETF 0.0024 13.09 3.48343
Avantis International Small Cap Value ETF 0.00232 14.36 4.23496
SPDR Portfolio MSCI Global Stock Market ETF 0.00123 17.99 2.19607
Vanguard ESG International Stock ETF 0 6.39 3.07501
0.0110.243.31



Head Job title Payment Year of birth
Dr. Zhongjie Pu Executive Chairman N/A 1963 (62 years)
Dr. Ziye Sui M.D., Ph.D. CEO & Director 2.97M 1981 (44 years)
Ms. Yunyi Li CFO & Board Secretary N/A 1980 (45 years)
Dr. Minmin Qin Ph.D. Chief Technology Officer N/A 1958 (67 years)
Ms. Siu Kuen Lai FCIS, FCS Joint Company Secretary N/A 1976 (49 years)
Ms. Lixuan Zhao Supervisor & Investor Relations Director 1992 (33 years)

Address: China, Shanghai, No. 651 Lianheng Road - open in Google maps, open in Yandex maps
Website: https://www.lepubiopharma.com